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Nitric oxide (NO) is suggested to play a role in mediating pulmonary injury. However, interspecies
differences appear to exist in the ability of alveolar macrophages (AM) to express the inducible
nitric oxide synthase (iNOS) and to generate NO. The purpose of this study was to compare iNOS
expression and NO production by rat, hamster, monkey, and human AM using the identical
experimental conditions in vitro. As AM donors, CD rats, Syrian golden hamsters, cynomolgus
monkeys, and nonsmoking, healthy human volunteers were used. The AM were obtained by
bronchoalveolar lavage and stimulated in vitro with various concentrations and combinations of
lipopolysaccharide (LPS) and interferon-y (IFN-y). The oxidation product of NO, nitrite, was
measured in the AM supernatant by the Griess reaction. The expression of iNOS in AM was
detected using immunocytochemistry and immunoblotting. The expression of iNOS mRNA was
assessed by reverse transcriptase-polymerase chain reaction (RT-PCR). Rat AM, stimulated with
either LPS or IFN-y, produced nitrite in a time- and dose-dependent manner. Combination of LPS
and IFN-y resulted in a significantly enhanced nitrite formation. However, none of the treatments
was able to induce hamster, monkey, or human AM to release measurable amounts of nitrite.
Whereas expression of iNOS protein was only detected in stimulated rat AM, expression of iNOS
mRNA was found in unstimulated and stimulated rat AM, slightly in stimulated hamster AM, but
not in monkey and human AM. In conclusion, our findings point to distinct regulatory
mechanisms of the NO pathway in AM from these four different species. Environ Health
Perspect 105(Suppl 4):1297-1300 (1997)
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Introduction
Species differences in response to various
agents are well known in biomedical
research. Ifsuch differences are identified
and characterized at the cellular and molec-
ular level, they might help to improve the
knowledge ofthe pathomechanisms ofcer-
tain diseases. For two ofthe rodent species
used in inhalation toxicology, rat and ham-
ster, such species differences have already
been reported concerning their pulmonary
reactions to inhalation ofpure oxygen (1),
diesel soot (2), or mineral fibers (3). After
inhalation ofpathogenic material, alveolar
macrophages (AM) constitute one of the
first lines ofcellular defense. Interaction of
AM with particles or fibers might result in
the formation of reactive oxygen species,
such as superoxide anion, and reactive
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nitrogen species, such as nitric oxide (NO)
(4). The reaction ofsuperoxide anion with
NO forms a potent oxidant, peroxynitrite,
which may contribute to inflammatory
tissue damage (5,6). The production of
NO and other reactive nitrogen intermedi-
ates is already well established for cytokine-
activated rat and mouse AM (7-10).
However, the presence ofsuch a pathway in
monocytes/macrophages from a number of
species, including humans, is the subject of
great controversy (11-16). Recently, we
reported that hamster AM, in contrast to
rat AM, lack the ability to express the
inducible nitric oxide synthase (iNOS)
protein and to release detectable amounts
of NO after lipopolysaccharide (LPS) and
cytokine stimulation in vitro (7). The
objective ofthe work presented here was to
extend these studies by comparing the
iNOS expression and NO formation
by AM from the two rodent species rat
and hamster and the two primate species
monkey and human using the identical
experimental conditions in vitro.
Methods
AlveolarMacrophage Donors
CD rats (Crl:CD(SN)BR; 250-350 g) and
Syrian golden hamsters (Lak:LVG(SYR)BR;
120-150 g) were obtained from Charles
River (Sulzfeld, Germany) and kept in a
conventional, nonbarrier rodent housing
unit. Water and standard rodent laboratory
diets (ssniff, Soest, Germany) were supplied
ad libitum. Cynomolgus monkeys were
born and raised at the institutional animal
holding facilities. The human samples were
obtained from nonsmoking male and female
volunteers, 20 to 30 years ofage, with no
historyofrecent pulmonary disease.
Cell Isolation andCulture
AM were obtained by bronchoalveolar
lavage (BAL). Rats and hamsters were anes-
thetized by an ip injection ofsodium pen-
tobarbital (rat, 30 mg/kg bw; hamster, 24
mg/kg bw). The lungs were mobilized and
lavaged in situ as described by 56orger et al.
(7). Fiberoptic bronchoscopy with BAL
was performed in monkeys under general
anesthesia with ketamine (15 mg/kg bw)
and xylazine (2 mg/kg bw) and in human
volunteers under local anesthesia as
decribed by Krombach et al. (17) and Behr
et al. (18). For each species studied, the
procedure ofprocessing the BAL samples
was identical. The pooled samples were
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centrifuged at 300xg for 10 min; the cell
pellet was washed twice, and resuspended
in RPMI 1640 (Seromed, Munich,
Germany) supplemented with L-glutamine,
gentamycin (0.16 mg/ml), and 10% heat-
inactivated fetal bovine serum (Gibco
BRL, Eggenstein, Germany). Total cell
counts were assessed with a standard hema-
cytometer (Coulter Electronics, Krefeld,
Germany). Air-dried cytocentrifuge smears
(500 rpm x 5 min) served to identify the
cellular populations after staining with
May-Griinwald-Giemsa. The preparations
contained about 97 to 100% AM, as char-
acterized by morphologic criteria. The cell
viability was determined by trypan blue
exclusion and was greater than 90% for rat,
hamster, and monkey AM, and greater
than 75% for human AM. Lavaged cells
were then plated to 96-well flat-bottomed
cell culture plates (Nunclon Delta, Roskilde,
Denmark) at a density of0.2x 106 cells/well
and cultured for 2 hr at 37°C and 5%
C02/95% air. The nonadherent cells were
removed with 37°C warm RPMI 1640
medium, and the adherent cells were cov-
ered with 200 pl ofmedium. The AM were
treated for 24 hr with either Escherichia
coli LPS (1, 10, 100, and 1000 ng/ml) or
interferon-y (IFN-y) (1, 10, and 100
U/mI). LPS was purchased from Sigma
Chemie (Taufkirchen, Germany), rat
specific IFN-y came from Innogenetics
(Ismaning, Germany), and human recombi-
nant IFN-y (for human, monkey, and ham-
ster cells) was from Boehringer Mannheim
(Mannheim, Germany).
MeasurementofNltricOxide
Production
The NO concentration in AM supernatants
was determined by measuring the oxida-
tion product nitrite with the Griess reac-
tion using a microplate assay method as
described by Ding et al. (19). Nitrite con-
centrations were calculated from a standard
sodium nitrite curve.
Immunoqtochemistry
The expression of iNOS protein in AM
was determined after stimulation with
either 100 ng/ml LPS or 10 ng/ml LPS
plus 100 U/ml IFN-y for 20 hr at 37°C.
Immunocytochemistry was performed as
described earlier (7) using apolyclonal rab-
bit antimouse iNOS antibody (Dianova,
Hamburg, Germany) that cross-reacts with
rat and human iNOS according to the
manufacturer's instructions. Binding ofthe
antibody to hamster iNOS was verified by
immunohistochemistry ofpancreatic tissue
sections taken from animals 18 hrafterbolus
injection ofLPS (5 mg/kg bw, iv) (data not
shown). Binding ofthe antibody to monkey
iNOS has not been explored so far, yet the
degree ofthe homology among amino acid
sequences ofiNOS between rodents and
humans is about 80 to 94% (20).
Immunoblotting
Immunoblotting was performed as described
previously (7). Briefly, AM were cultured
with 100 ng/ml LPS or 10 ng/ml LPS plus
100 U/ml IFN-'y for 24 hr at 37°C. After
incubation and lysis ofcells, cell extracts
were run on a sodium dodecyl sulfate
(SDS)-polyacrylamide gel and transferred
to a nitrocellulose membrane. After applica-
tion to the iNOS antibody, the membrane
was exposed to an alkaline phosphatase-con-
jugated goat antirabbit IgG and developed
with 5-bromo-4-chloro-3-indolylphosphate/
nitro blue tetrazolium (BCIP/NBT).
ReverseTranscriptase-Polymerase
Chain Reaction
Total RNA were extracted from AM after
incubation with 10 ng/ml LPS plus 100
U/ml IFN-y for 16 hr using reverse tran-
scriptase (RT). The cDNA was amplified
by polymerase chain reaction (PCR) with a
DNA thermal cycler (Perkin Elmer, Cetus
Corp., Norwalk, CT). The amplification
reaction was carried out as described earlier
(7). Oligonucleotide primers for iNOS were
CACAAGGCCACATCGGA'lTlC (sense)
and TGCATACCACTTCAACCCGAG
(antisense), which correspond to the
murine macrophage iNOS (21), and
AGTTTCTGGCAGCAACGG (sense)
and TTAAGTTCTGTGTGCCGGCAG
(antisense) (MWG-Biotech, Ebersberg,
Germany), which correspond to human
iNOS (22).
Results
FormationofNitricOxide
To induce NO formation by AM, we
incubated the cells with various concentra-
tions of LPS or IFN-y. Stimulation with
either LPS or IFN-y resulted in a dose-
dependent NO release by rat AM. In con-
trast, none of these stimuli was able to
induce a detectable NO release by hamster,
monkey, or human AM (Table 1). Next, we
investigated whether stimulation with LPS
plus IFN-y would either increase the NO
generation by rat AM or actually induce an
NO release by hamster, monkey, or human
AM. In this series ofexperiments, AM were
cultured with 1 ng/ml LPS and graded con-
centrations ofIFN-,y at the same time. As
shown in Table 2, simultaneous incubation
with LPS plus IFN-y resulted in a potenti-
ated NO production by ratAM, but had no
effect on either hamster orprimateAM.
ExpressionofiNOS Protein
To analyze the expression ofiNOS protein
by rodent and primate AM, we used
immunocytochemical and immunoblotting
methods. After immunocytochemical
Table 1. Nitrite formation (nmol/mg protein) by rat, hamster, monkey, and human alveolar macrophages upon
stimulation with LPS or IFN-,y.
Rat Hamster Monkey Human
Stimulus n=6 n=3 n=3 n=3
None -a
1 ng/ml lPS 101.9± 23.8b _ _
10 ng/ml LPS 225.9 ± 54.5 - - ND
100 ng/ml LPS 257.6 ± 50.1
1000 ng/ml LPS 265.5± 55.1 - - ND
1 U/mI IFN-y 15.0 ± 15.0 - - ND
10 U/ml IFN-y 124.7 ± 6.8 - - ND
100 U/ml IFN-y 195.2 ±35.8
ND, not determined. "Below detection limit of 0.5 nmol. bValues are means + SEM.
Table 2. Effect of IFN-y on LPS-induced nitrite formation (nmol/mg protein) by rat, hamster, monkey, and human
alveolar macrophages.
Rat Hamster Monkey Human
Stimulus n=6 n=3 n=3 n=3
1 ng/ml LPS 101.9 23.8a .b
1 ng/ml LPS + 1 U/ml IFN-y 137.2 21.5 - - ND
1 ng/ml LPS + 10 U/ml IFN-y 181.7 23.4 - - ND
1 ng/ml LPS + 100 U/ml IFN-y 278.2 21.9
ND, notdetermined. "Values are means ± SEM. bBelow detection limit of 0.5 nmol.
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Table 3. Expression of iNOS protein and mRNA in rat, hamster, monkey, and human alveolar macrophages.
Method Stimuli Rat Hamster Monkey Human
Immunocytochemistry None
LPS ++ - -
LPS + IFN-y - -
Immunoblotting None
LPS ++ - -
LPS + IFN-,y ++- -
RT-PCR None ++
LPS+IFN-y + + -
staining with a polyclonal rabbit antimouse
iNOS antibody, the native protein was
labeled only in stimulated rat AM, but not
in hamster, monkey, or human AM (Table
3). Consistent with the immunocyto-
chemical data, the appearance ofa band at
approximately 125 kD, corresponding to
the molecular weight ofiNOS protein, was
noted only in stimulated rat AM. In con-
trast, no specific reactivity was found in
hamster, monkey, and human AM,
whether untreated or treated (Table 3).
Expression ofiNOS mRNA
RT-PCR assay was used to detect iNOS
mRNA expression in rat, hamster, monkey,
and human AM. Using the mouse iNOS
primer, a PCR product ofpredicted size of
741 bp was found in unstimulated and
stimulated rat AM, and in stimulated ham-
ster AM. As reported earlier, iNOS mRNA
appeared to be expressed at a lower level in
hamster AM compared to rat AM (7). In
contrast, iNOS transcripts were not found
in monkey AM, using mouse or human
iNOS primers, nor in human AM.
Discussion
Among two of the rodent species often
used in inhalation toxicology, rat and ham-
ster, species differences concerning their
pulmonary reactions to inhalation ofpure
oxygen, diesel soot, and mineral fibers have
already been reported (1-3). However, the
cellular and molecular mechanisms causing
such differences remain unclear. Recently,
we reported that hamster AM, in contrast
to rat AM, lack the ability to express iNOS
and to produce NO after stimulation with
LPS and/or IFN-y in vitro (7). NO and its
reactive metabolites may play a crucial role
in inflammation, tissue damage, mutagene-
sis, and carcinogenesis (23). The produc-
tion of NO and other reactive nitrogen
intermediates has already been well estab-
lished for cytokine-stimulated rat and
mouse macrophages (8-10), whereas the
presence and regulation of the NO path-
way in monocytes/macrophages from vari-
ous species, including humans, still
remains controversial (7,11-16,24-27).
Here, we focused our interest on compar-
ing iNOS expression and NO production
by AM from two rodent species, rat and
hamster, and two primate species, monkey
and human, under identical experimental
conditions in vitro.
Our data presented here confirm previ-
ous reports on the dose-dependent NO for-
mation by rat AM (9,10) and the lack of
NO generation by hamster AM upon incu-
bation with LPS and/or IFN-y (7). Now,
we have extended these findings by demon-
strating also that AM from two primate
species, cynomolgus monkey and human,
were not activated by LPS and/or IFN-y to
form detectable amounts ofNO. In support
ofthis finding, several studies suggested that
primate monocytes/macrophages release no
NO, or only modest amounts, after incuba-
tion with LPS and/or certain cytokines
in vitro (11-14,24,25).
In addition, we have shown that both
iNOS mRNA and protein were expressed
in stimulated rat AM. These results agree
with those previously reported for rat AM
(7,10,26). iNOS mRNA was barely tran-
scribed in activated hamster, but not in
monkey and human AM, and iNOS pro-
tein was not expressed by AM from either
species. Nevertheless, recent reports suggest
that human AM from patients with lung
inflammation occasionally express the
iNOS protein (26) and that AM from
patients with tuberculosis transcribe iNOS
mRNA (27). However, we had the oppor-
tunity to examine AM from a heavy smoker
with bronchial carcinoma and did not
detect any expression ofiNOS protein or
iNOS mRNA (unpublished data).
The data reported here extend our
previous observations that monkey and
human AM, in contrast to rat AM, failed
to express iNOS and to generate NO upon
stimulation with LPS and/or IFN-y in
vitro. Thus, in their inability to express the
iNOS protein and to generate NO in vitro,
hamster AM tend to resemble monkey and
human AM more than rat AM. These
results suggest marked discrepancies among
rodent species concerning the presence and
regulation ofthe high-output NO pathway
in AM, whereas among primate species
such differences apparently do not exist. If
these in vitro data on interspecies differ-
ences in iNOS expression and NO produc-
tion are confirmed in vivo, they might
improve our knowledge ofthe molecular
mechanisms causing the disparate pul-
monary responses of different species to
inhaled irritants or toxicants.
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